A thorough pelvic lymph node dissection in presence of positive margins associated with better clinical outcomes in radical cystectomy patients.

PubWeight™: 2.06‹?› | Rank: Top 2%

🔗 View Article (PMID 19371932)

Published in Urology on April 15, 2009

Authors

Daniel Canter1, Thomas J Guzzo, Matthew J Resnick, Meredith R Bergey, Seema S Sonnad, John Tomaszewski, Keith VanArsdalen, S Bruce Malkowicz

Author Affiliations

1: Department of Surgery, Division of Urology, Hospital of University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA. daniel.canter@uphs.upenn.edu

Articles by these authors

Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era. Cancer (2002) 3.72

Breast reconstruction with free tissue transfer from the abdomen in the morbidly obese. Plast Reconstr Surg (2011) 3.38

An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma. J Urol (2003) 3.21

Factors associated with satisfaction with prostate cancer care: results from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE). BJU Int (2012) 2.88

Incidence of benign pathologic findings at partial nephrectomy for solitary renal mass presumed to be renal cell carcinoma on preoperative imaging. Urology (2006) 2.59

Optimizing bladder cancer locoregional failure risk stratification after radical cystectomy using SWOG 8710. Cancer (2014) 2.48

A boosted Bayesian multiresolution classifier for prostate cancer detection from digitized needle biopsies. IEEE Trans Biomed Eng (2010) 2.41

Mammographic density measured with quantitative computer-aided method: comparison with radiologists' estimates and BI-RADS categories. Radiology (2006) 2.40

Optical properties of human prostate at 732 nm measured in mediated photodynamic therapy. Photochem Photobiol (2005) 2.33

Long-term survival after radical prostatectomy for men with high Gleason sum in pathologic specimen. Urology (2010) 2.27

A Comparison between DIEP and muscle-sparing free TRAM flaps in breast reconstruction: a single surgeon's recent experience. Plast Reconstr Surg (2010) 2.16

Resident and RN perceptions of the impact of a medical emergency team on education and patient safety in an academic medical center. Crit Care Med (2009) 2.11

Minimal tumor volume may provide additional prognostic information in good performance patients after radical prostatectomy. Urology (2007) 2.09

Is ultrasound imaging inferior to computed tomography or magnetic resonance imaging in evaluating renal mass size? Urology (2012) 2.03

Toremifene to reduce fracture risk in men receiving androgen deprivation therapy for prostate cancer. J Urol (2010) 1.99

The burden of depression in prostate cancer. Psychooncology (2011) 1.79

Toremifene improves lipid profiles in men receiving androgen-deprivation therapy for prostate cancer: interim analysis of a multicenter phase III study. J Clin Oncol (2008) 1.72

Repeat prostate biopsy and the incremental risk of clinically insignificant prostate cancer. Urology (2011) 1.70

Interstitial fluorescence spectroscopy in the human prostate during motexafin lutetium-mediated photodynamic therapy. Photochem Photobiol (2007) 1.69

Preoperative parameters, including percent positive biopsy, in predicting seminal vesicle involvement in patients with prostate cancer. J Urol (2006) 1.64

An acute care surgery model improves outcomes in patients with appendicitis. Ann Surg (2006) 1.62

A novel risk stratification to predict local-regional failures in urothelial carcinoma of the bladder after radical cystectomy. Int J Radiat Oncol Biol Phys (2012) 1.61

Stereotactic biopsy of brain stem masses: Decision analysis and literature review. Surg Neurol (2006) 1.55

Initial experience with laparoscopic transvesical ureteral reimplantation at the Children's Hospital of Philadelphia. J Urol (2006) 1.55

Trauma leadership: does perception drive reality? J Surg Educ (2011) 1.54

Impact on renal function of percutaneous thermal ablation of renal masses in patients with preexisting chronic kidney disease. J Vasc Interv Radiol (2011) 1.54

Racial differences in quality of life following prostate cancer diagnosis. Urology (2010) 1.51

Impact of race on prostate-specific antigen outcome after radical prostatectomy for clinically localized adenocarcinoma of the prostate. J Clin Oncol (2002) 1.47

Identification of clinically significant prostate cancer by prostate-specific antigen screening. Arch Intern Med (2004) 1.46

Improved nurse job satisfaction and job retention with the transition from a "mandatory consultation" model to a "semiclosed" surgical intensive care unit: a 1-year prospective evaluation. Crit Care Med (2006) 1.44

Women on professional society and journal editorial boards. J Natl Med Assoc (2007) 1.44

Vena caval transection during retroperitoneoscopic nephrectomy: report of the complication and review of the literature. J Urol (2004) 1.43

Cascaded discrimination of normal, abnormal, and confounder classes in histopathology: Gleason grading of prostate cancer. BMC Bioinformatics (2012) 1.42

Factors influencing the length of stay after radical cystectomy: implications for cancer care and perioperative management. Ann Surg Oncol (2014) 1.42

Enucleation of renal cell carcinoma with ablation of the tumour base. BJU Int (2008) 1.41

Free flap breast reconstruction in advanced age: is it safe? Plast Reconstr Surg (2009) 1.40

Association between utility and treatment among patients with prostate cancer. Qual Life Res (2010) 1.39

Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African American men. Cancer Epidemiol Biomarkers Prev (2005) 1.37

Choosing the best operation for chronic subdural hematoma: a decision analysis. J Neurosurg (2010) 1.33

Determining histology-MRI slice correspondences for defining MRI-based disease signatures of prostate cancer. Comput Med Imaging Graph (2011) 1.28

Diffuse fibrous pseudotumor of the testicular tunics associated with an inflamed hydrocele. Arch Pathol Lab Med (2003) 1.27

Motexafin lutetium-photodynamic therapy of prostate cancer: short- and long-term effects on prostate-specific antigen. Clin Cancer Res (2008) 1.26

Digital pathology evaluation in the multicenter Nephrotic Syndrome Study Network (NEPTUNE). Clin J Am Soc Nephrol (2013) 1.24

Racial differences in attitudes toward innovative medical technology. J Gen Intern Med (2006) 1.23

Shunts in normal-pressure hydrocephalus: do we place too many or too few? J Neurosurg (2006) 1.22

CYP3A4, CYP3A5, and CYP3A43 genotypes and haplotypes in the etiology and severity of prostate cancer. Cancer Res (2004) 1.21

An active learning based classification strategy for the minority class problem: application to histopathology annotation. BMC Bioinformatics (2011) 1.20

Renal medullary carcinoma: molecular, pathological and clinical evidence for treatment with topoisomerase-inhibiting therapy. BJU Int (2009) 1.18

150 years of treating severe traumatic brain injury: a systematic review of progress in mortality. J Neurotrauma (2010) 1.17

Real-time in situ monitoring of human prostate photodynamic therapy with diffuse light. Photochem Photobiol (2007) 1.17

Risk factors and complications in free TRAM flap breast reconstruction. Ann Plast Surg (2006) 1.16

Integrated diagnostics: a conceptual framework with examples. Clin Chem Lab Med (2010) 1.14

UBIAD1 mutation alters a mitochondrial prenyltransferase to cause Schnyder corneal dystrophy. PLoS One (2010) 1.12

An interaction between apolipoprotein E and TERE1 with a possible association with bladder tumor formation. J Cell Biochem (2005) 1.12

Expression of the proto-oncogene Axl in renal cell carcinoma. DNA Cell Biol (2003) 1.12

Endorectal T2-weighted MRI does not differentiate between favorable and adverse pathologic features in men with prostate cancer who would qualify for active surveillance. Urol Oncol (2012) 1.12

Racial differences in medical mistrust among men diagnosed with prostate cancer. Cancer (2009) 1.11

Screening tests for normal-pressure hydrocephalus: sensitivity, specificity, and cost. J Neurosurg (2006) 1.11

Complications following thoracic trauma managed with tube thoracostomy. Injury (2011) 1.10

The bladder tumor suppressor protein TERE1 (UBIAD1) modulates cell cholesterol: implications for tumor progression. DNA Cell Biol (2011) 1.07

Evaluation of prostate cancer characteristics in four populations worldwide. Can J Urol (2008) 1.06

Ethnic variation in return to baseline values of patient-reported outcomes in older prostate cancer patients. Cancer (2007) 1.04

Statistical methods in the surgical literature. J Am Coll Surg (2006) 1.00

Comprehensive handbook for developing a bladder cancer cystectomy database. Urol Oncol (2011) 0.99

Using a population-based observational cohort study to address difficult comparative effectiveness research questions: the CEASAR study. J Comp Eff Res (2013) 0.99

A meta-analysis of the performance characteristics of the free prostate-specific antigen test. Urology (2006) 0.99

Health-related quality of life and satisfaction with care among older men treated for prostate cancer with either radical prostatectomy or external beam radiation therapy. BJU Int (2006) 0.99

Increased EZH2 protein expression is associated with invasive urothelial carcinoma of the bladder. Urol Oncol (2011) 0.99

Comparison between the analgesic efficacy of transversus abdominis plane (TAP) block and placebo in open retropubic radical prostatectomy: a prospective, randomized, double-blinded study. J Clin Anesth (2013) 0.99

Impact of surgical technique (open vs laparoscopic vs robotic-assisted) on pathological and biochemical outcomes following radical prostatectomy: an analysis using propensity score matching. BJU Int (2010) 0.98

Women authors of surgical research. Arch Surg (2005) 0.98

Satisfaction with care: a measure of quality of care in prostate cancer patients. Med Decis Making (2009) 0.97

Degree of tumor FDG uptake correlates with proliferation index in triple negative breast cancer. Mol Imaging Biol (2009) 0.97

A Co2N2 diamond-core resting state of cobalt(I): a three-coordinate CoI synthon invoking an unusual pincer-type rearrangement. Angew Chem Int Ed Engl (2006) 0.96

TERE1, a novel gene affecting growth regulation in prostate carcinoma. Prostate (2003) 0.96

Multi-field-of-view strategy for image-based outcome prediction of multi-parametric estrogen receptor-positive breast cancer histopathology: Comparison to Oncotype DX. J Pathol Inform (2012) 0.95

The tumor suppressor TERE1 (UBIAD1) prenyltransferase regulates the elevated cholesterol phenotype in castration resistant prostate cancer by controlling a program of ligand dependent SXR target genes. Oncotarget (2013) 0.95

Chemosensitivity of malignant ovarian-type surface epithelial tumor of testis. Urology (2005) 0.94

Meta-analysis of cranial CT scans in children. A mathematical model to predict radiation-induced tumors. Pediatr Neurosurg (2008) 0.94

Alterations in tropomyosin isoform expression in human transitional cell carcinoma of the urinary bladder. Int J Cancer (2004) 0.93

Multi-field-of-view framework for distinguishing tumor grade in ER+ breast cancer from entire histopathology slides. IEEE Trans Biomed Eng (2013) 0.93

Evolution of operative techniques for the treatment of single-suture metopic synostosis. Ann Plast Surg (2007) 0.93

Improved survival after pulmonary metastasectomy for soft tissue sarcoma. J Thorac Oncol (2011) 0.92